review glp-1 GLP-1-based therapies for diabetes, obesity and beyond GLP-1 receptor agonists in people

Moreover, liraglutide 3.0 mg (i.e., the dose level approved for weight management for this GLP-1 RA) in combination with lifestyle intervention markedly reduced the presence of visceral fat over a period of 40 weeks (Neeland et al., 2021)

Adv Ther

Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study

As in the pathophysiology of DR, RGCs are particularly vulnerable to oxidative stressors in glaucoma

She has received the Canadian Governor Generals bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals

PMID: 12475787